Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

AIMS/HYPOTHESIS: Individuals with type 2 diabetes mellitus and subclinical inflammation have stimulated coagulation, activated platelets and endothelial dysfunction. Recent studies with the direct factor Xa inhibitor rivaroxaban in combination with low-dose aspirin demonstrated a significant reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pistrosch, Frank, Matschke, Jan B., Schipp, Dorothea, Schipp, Bernhard, Henkel, Elena, Weigmann, Ingo, Sradnick, Jan, Bornstein, Stefan R., Birkenfeld, Andreas L., Hanefeld, Markolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563606/
https://www.ncbi.nlm.nih.gov/pubmed/34495376
http://dx.doi.org/10.1007/s00125-021-05562-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563606/
https://www.ncbi.nlm.nih.gov/pubmed/34495376
http://dx.doi.org/10.1007/s00125-021-05562-9

Ejemplares similares